Avita Medical
RCEL
73 hedge funds and large institutions have $20.4M invested in Avita Medical in 2026 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 24 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 21
2.86% less ownership
Funds ownership: 18.88% → 16.02% (-2.9%)
8% less funds holding
Funds holding: 79 → 73 (-6)
17% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 24
17% less call options, than puts
Call options by funds: $109K | Put options by funds: $131K
67% less capital invested
Capital invested by funds: $61.9M → $20.4M (-$41.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$1.23M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$978K |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$570K |
| 4 |
QCM
Quantinno Capital Management
New York
|
+$357K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$275K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$42.5M |
| 2 |
BlackRock
New York
|
-$2.45M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.29M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$876K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$493K |
RCEL Hedge Fund Activity: Q2 2026 in Review
73 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q2 2026, worth a combined $20.4M — down 67% from $61.9M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of RCEL and 20 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 25 added.
The largest buyer was Marshall Wace, adding an estimated $1.23M. The largest seller was OrbiMed, exiting entirely with an estimated $42.5M sold.
- 73 institutional investors held Avita Medical (RCEL) as of Q2 2026, down from 79 in Q1 2026.
- Funds reported $20.4M of Avita Medical stock for Q2 2026, down 67% quarter-over-quarter.
- 20 funds opened new Avita Medical positions in Q2 2026 and 24 closed out, a net change of -4 holders.
- The largest Avita Medical buyer in Q2 2026 was Marshall Wace, an estimated $1.23M added.
- The largest Avita Medical seller in Q2 2026 was OrbiMed, an estimated $42.5M sold.
Based on aggregated 13F filings for Q2 2026.